Cargando…
A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response
Despite recent advances, there remains a significant unmet need for the development of new targeted therapies for triple-negative breast cancer (TNBC). Although the heat shock protein HSP90 is a promising target, previous inhibitors have had issues during development including undesirable induction...
Autores principales: | Kim, Ji Young, Cho, Tae-Min, Park, Jung Min, Park, Soeun, Park, Minsu, Nam, Kee Dal, Ko, Dongmi, Seo, Juyeon, Kim, Seongjae, Jung, Eunsun, Farrand, Lee, Nguyen, Cong-Truong, Hoang, Van-Hai, Thanh La, Minh, Ann, Jihyae, Nam, Gibeom, Park, Hyun-Ju, Lee, Jeewoo, Kim, Yoon-Jae, Seo, Jae Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166677/ https://www.ncbi.nlm.nih.gov/pubmed/35501463 http://dx.doi.org/10.1038/s41388-022-02269-y |
Ejemplares similares
-
A novel HSP90 inhibitor targeting the C-terminal domain attenuates trastuzumab resistance in HER2-positive breast cancer
por: Park, Jung Min, et al.
Publicado: (2020) -
β-Escin overcomes trastuzumab resistance in HER2-positive breast cancer by targeting cancer stem-like features
por: Park, Soeun, et al.
Publicado: (2022) -
Ebastine impairs metastatic spread in triple-negative breast cancer by targeting focal adhesion kinase
por: Seo, Juyeon, et al.
Publicado: (2023) -
Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR
por: Kim, Seongjae, et al.
Publicado: (2023) -
The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells
por: Park, Soeun, et al.
Publicado: (2021)